Cost–benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis-Reference-Cited by-同舟云学术

Cost–benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis

Published:2015-09 Issue:9 Volume:37 Page:2019-2027
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Cho Sung-Yeon,Lee Dong-Gun,Choi Jae-Ki,Lee Hyo-Jin,Kim Si-Hyun,Park Sun-Hee,Choi Su-Mi,Choi Jung-Hyun,Yoo Jin-Hong,Kim Yoo-Jin,Kim Hee-Je,Min Woo-Sung,Back Heejung,Kang Sukhyun,Lee Eui-Kyung

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Our 2015 approach to invasive pulmonary aspergillosis;Liss;Mycoses,2015

2. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis;Tsitsikas;Med Mycol,2012

3. Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report;Pagano;Clin Infect Dis,2007

4. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study;Pagano;Haematologica,2010

5. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia;Cornely;N Engl J Med,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluconazole and levofloxacin prophylaxis are ineffective strategies for preventing infections in acute myeloid leukemia patients undergoing chemotherapy;Cancer Epidemiology;2024-08

2. Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2023-03-01

3. Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections;Supportive Care in Cancer;2020-05-21

4. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study;Journal of Oncology Pharmacy Practice;2019-09-29

5. Clinical and economic impact of clinical pharmacist intervention in a hematology unit;Journal of Oncology Pharmacy Practice;2019-09-29